Listar por autor "Kalavrizioti, D."
Mostrando ítems 1-6 de 6
-
A 40.7 kDa Rpp30/Rpp1 homologue is a protein subunit of Dictyostelium discoideum RNase P holoenzyme
Vourekas, A.; Kalavrizioti, D.; Zarkadis, I. K.; Spyroulias, G. A.; Stathopoulos, C.; Drainas, D. (2007)RNase P is an essential and ubiquitous endonuclease that mediates the maturation of the 5' ends of all precursor tRNA molecules. The holoenzyme from Dictyostelium discoideum possesses RNA and protein subunits essential for ... -
Composition of the ribonucleoprotein complex of ribonuclease P from Dictyostelium discoideurn
Vourekas, A.; Kalavrizioti, D.; Theodorakopoulou, O.; Stamatopoulou, V.; Toumpeki, C.; Stathopoulos, C.; Drainas, D. (2006) -
Kinetics of inhibition of ribonuclease P activity by peptidyltransferase inhibitors: Effect of antibiotics on RNase P
Kalavrizioti, D.; Vourekas, A.; Tekos, A.; Tsagla, A.; Stathopoulos, C.; Drainas, D. (2003)A cell-free system derived from Dictyostelium discoideum has been used to study the kinetics of inhibition of RNase P by puromycin, amicetin and blasticidin S. Detailed kinetic analysis showed that the type of inhibition ... -
Modulation of catalytic RNA biological activity by small molecule effectors
Vourekas, A.; Kalavrizioti, D.; Stathopoulos, C.; Drainas, D. (2006)Catalytic RNAs, known as ribozymes, act as true enzymes and are implicated in important biological processes, such as protein synthesis, mRNA splicing, transcriptional regulation and retroviral replication. Ribozymes are ... -
RNA-Mediated therapeutics: From gene inactivation to clinical application
Kalavrizioti, D.; Vourekas, A.; Stamatopoulou, V.; Toumpeki, C.; Giannouli, S.; Stathopoulos, C.; Drainas, D. (2006)The specific targeting and inactivation of gene expression represents nowdays the goal of the mainstream basic and applied biomedical research. Both researchers and pharmaceutical companies, taking advantage of the vast ... -
T helper (Th)-cytokines in the urine of patients with primary glomerulonephritis treated with immunosuppressive drugs: Can they predict outcome?
Kalavrizioti, D.; Gerolymos, M.; Rodi, M.; Kalliakmani, P.; Provatopoulou, S.; Eleftheriadis, T.; Mouzaki, A.; Goumenos, D. S. (2015)Background: Glomerulonephritides (GNs) represent common causes of chronic kidney disease associated with a wide spectrum of clinical and histological features. Various factors that activate the inflammatory cascade are ...